NSE · BALAXI

BALAXI PHARMACEUTICALS LIMITED

Sector: Healthcare · ISIN: INE618N01022

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#2,772

of 5,072 stocks

▼ 261W

Peak #2,746 · 21 Sep 2026

Operating in Healthcare, BALAXI PHARMACEUTICALS LIMITED carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and remains firmly promoter-controlled, with promoters holding 66%. Ownership as of Jun 2026.

Market Cap

125.98 Cr

P/E Ratio

87.77

P/B Ratio

0.51

ROE

0.57%

ROCE

3.35%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	80.68 Cr	70.71 Cr	72.54 Cr	56.18 Cr
Net Profit	1.30 Cr	61.28 L	30.50 L	20.90 L
EPS	0.24	0.11	0.06	0.04
Operating Profit	2.82 Cr	2.39 Cr	2.63 Cr	2.27 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

65.99%

Public

34.01%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
30 May 2024	Split	Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
01 Jul 2022	Dividend	Annual General Meeting/Dividend - Rs 0.50 Per Share
21 Sep 2017	Other	Annual General Meeting
22 Sep 2016	Other	Annual General Meeting

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs